Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1987;80(Suppl 15):16–24.

Rationale of modern dietary recommendations in cystic fibrosis.

J M Littlewood 1, A MacDonald 1
PMCID: PMC1290609  PMID: 3116241

Full text

PDF
16

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams C. K., Hamosh M., Hubbard V. S., Dutta S. K., Hamosh P. Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency. J Clin Invest. 1984 Feb;73(2):374–382. doi: 10.1172/JCI111222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adrian T. E., McKiernan J., Johnstone D. I., Hiller E. J., Vyas H., Sarson D. L., Bloom S. R. Hormonal abnormalities of the pancreas and gut in cystic fibrosis. Gastroenterology. 1980 Sep;79(3):460–465. [PubMed] [Google Scholar]
  3. Allan J. D., Mason A., Moss A. D. Nutritional supplementation in treatment of cystic fibrosis of the pancreas. Am J Dis Child. 1973 Jul;126(1):22–26. doi: 10.1001/archpedi.1973.02110190018004. [DOI] [PubMed] [Google Scholar]
  4. Allen J. M., Penketh A. R., Adrian T. E., Lee Y. C., Sarson D. L., Hodson M. E., Batten J. C., Bloom S. R. Adult cystic fibrosis: postprandial response of gut regulatory peptides. Gastroenterology. 1983 Dec;85(6):1379–1383. [PubMed] [Google Scholar]
  5. Antonowicz I., Lebenthal E., Shwachman H. Disaccharidase activities in small intestinal mucosa in patients with cystic fibrosis. J Pediatr. 1978 Feb;92(2):214–219. doi: 10.1016/s0022-3476(78)80007-9. [DOI] [PubMed] [Google Scholar]
  6. Barclay R. P., Shannon R. S. Trial of artificial diet in treatment of cystic fibrosis of pancreas. Arch Dis Child. 1975 Jun;50(6):490–493. doi: 10.1136/adc.50.6.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Barry D. M., Reeve A. W. Increased incidence of gram-negative neonatal sepsis with intramuscula iron administration. Pediatrics. 1977 Dec;60(6):908–912. [PubMed] [Google Scholar]
  8. Berry H. K., Kellogg F. W., Hunt M. M., Ingberg R. L., Richter L., Gutjahr C. Dietary supplement and nutrition in children with cystic fibrosis. Am J Dis Child. 1975 Feb;129(2):165–171. doi: 10.1001/archpedi.1975.02120390009003. [DOI] [PubMed] [Google Scholar]
  9. Bradley J. A., Axon A. T., Hill G. L. Nocturnal elemental diet for retarded growth in a patient with cystic fibrosis. Br Med J. 1979 Jan 20;1(6157):167–167. doi: 10.1136/bmj.1.6157.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brown R. C., Chalmers D. M., Rowe V. L., Kelleher J., Littlewood J. M., Losowsky M. S. Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis. J Clin Pathol. 1982 May;35(5):547–549. doi: 10.1136/jcp.35.5.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Buts J. P., Morin C. L., Roy C. C., Weber A., Bonin A. One-hour blood xylose test: a reliable index of small bowel function. J Pediatr. 1978 May;92(5):729–733. doi: 10.1016/s0022-3476(78)80138-3. [DOI] [PubMed] [Google Scholar]
  12. CHUNG A. W., MORALES S., SNYDERMAN S. E., LEWIS J. M., HOLT L. E., Jr Studies in steatorrhea. Effect of the level of dietary fat upon the absorption of fat and other foodstuffs in idiopathic celiac disease and cystic fibrosis of the pancreas. Pediatrics. 1951 Apr;7(4):491–502. [PubMed] [Google Scholar]
  13. Chalmers D. M., Brown R. C., Miller M. G., Clarke P. C., Kelleher J., Littlewood J. M., Losowsky M. S. The influence of long-term cimetidine as an adjuvant to pancreatic enzyme therapy in cystic fibrosis. Acta Paediatr Scand. 1985 Jan;74(1):114–117. doi: 10.1111/j.1651-2227.1985.tb10930.x. [DOI] [PubMed] [Google Scholar]
  14. Chase H. P., Cotton E. K., Elliott R. B. Intravenous linoleic acid supplementation in children with cystic fibrosis. Pediatrics. 1979 Aug;64(2):207–213. [PubMed] [Google Scholar]
  15. Chase H. P., Long M. A., Lavin M. H. Cystic fibrosis and malnutrition. J Pediatr. 1979 Sep;95(3):337–347. doi: 10.1016/s0022-3476(79)80504-1. [DOI] [PubMed] [Google Scholar]
  16. Congden P. J., Bruce G., Rothburn M. M., Clarke P. C., Littlewood J. M., Kelleher J., Losowsky M. S. Vitamin status in treated patients with cystic fibrosis. Arch Dis Child. 1981 Sep;56(9):708–714. doi: 10.1136/adc.56.9.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Corey M., Gaskin K., Durie P., Levison H., Forstner G. Improved prognosis in CF patients with normal fat absorption. J Pediatr Gastroenterol Nutr. 1984;3 (Suppl 1):S99–105. doi: 10.1097/00005176-198400031-00016. [DOI] [PubMed] [Google Scholar]
  18. Crossley J. R., Elliott R. B., Smith P. A. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979 Mar 3;1(8114):472–474. doi: 10.1016/s0140-6736(79)90825-0. [DOI] [PubMed] [Google Scholar]
  19. Darling P. B., Lepage G., Leroy C., Masson P., Roy C. C. Effect of taurine supplements on fat absorption in cystic fibrosis. Pediatr Res. 1985 Jun;19(6):578–582. doi: 10.1203/00006450-198506000-00015. [DOI] [PubMed] [Google Scholar]
  20. DiMagno E. P., Go V. L., Summerskill W. H. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973 Apr 19;288(16):813–815. doi: 10.1056/NEJM197304192881603. [DOI] [PubMed] [Google Scholar]
  21. DiMagno E. P., Malagelada J. R., Go V. L., Moertel C. G. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med. 1977 Jun 9;296(23):1318–1322. doi: 10.1056/NEJM197706092962304. [DOI] [PubMed] [Google Scholar]
  22. Dowd P. S., Heatley R. V. The influence of undernutrition on immunity. Clin Sci (Lond) 1984 Mar;66(3):241–248. doi: 10.1042/cs0660241. [DOI] [PubMed] [Google Scholar]
  23. Durie P. R., Bell L., Linton W., Corey M. L., Forstner G. G. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut. 1980 Sep;21(9):778–786. doi: 10.1136/gut.21.9.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Durie P. R., Newth C. J., Forstner G. G., Gall D. G. Malabsorption of medium-chain triglycerides in infants with cystic fibrosis: correction with pancreatic enzyme supplement. J Pediatr. 1980 May;96(5):862–864. doi: 10.1016/s0022-3476(80)80559-2. [DOI] [PubMed] [Google Scholar]
  25. Ehrhardt P., Miller M. G., Littlewood J. M. Iron deficiency in cystic fibrosis. Arch Dis Child. 1987 Feb;62(2):185–187. doi: 10.1136/adc.62.2.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Elias E., Muller D. P., Scott J. Association of spinocerebellar disorders with cystic fibrosis or chronic childhood cholestasis and very low serum vitamin E. Lancet. 1981 Dec 12;2(8259):1319–1321. doi: 10.1016/s0140-6736(81)91342-8. [DOI] [PubMed] [Google Scholar]
  27. Elliott R. B. A therapeutic trial of fatty acid supplementation in cystic fibrosis. Pediatrics. 1976 Apr;57(4):474–479. [PubMed] [Google Scholar]
  28. FREYE H. B., KURTZ S. M., SPOCK A., CAPP M. P. LIGHT AND ELECTRON MICROSCOPIC EXAMINATION OF THE SMALL BOWEL OF CHILDREN WITH CYSTIC FIBROSIS. J Pediatr. 1964 Apr;64:575–579. doi: 10.1016/s0022-3476(64)80351-6. [DOI] [PubMed] [Google Scholar]
  29. Ferguson A., Merrett T. G., Littlewood J. M., Bolderson I. IgE antibodies to foods are not a feature of cystic fibrosis. Hum Nutr Clin Nutr. 1986 Jul;40(4):255–258. [PubMed] [Google Scholar]
  30. Fredrikzon B., Bläckberg L. Lingual lipase: an important lipase in the digestion of dietary lipids in cystic fibrosis? Pediatr Res. 1980 Dec;14(12):1387–1390. doi: 10.1203/00006450-198012000-00026. [DOI] [PubMed] [Google Scholar]
  31. Galabert C., Filliat M., Chazalette J. P. Fatty-acid composition of serum-lecithins in cystic-fibrosis patients without steatorrhoea. Lancet. 1978 Oct 21;2(8095):903–903. doi: 10.1016/s0140-6736(78)91620-3. [DOI] [PubMed] [Google Scholar]
  32. Goodchild M. C., Murphy G. M., Howell A. M., Nutter S. A., Anderson C. M. Aspects of bile acid metabolism in cystic fibrosis. Arch Dis Child. 1975 Oct;50(10):769–778. doi: 10.1136/adc.50.10.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Gow R., Bradbear R., Francis P., Shepherd R. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Lancet. 1981 Nov 14;2(8255):1071–1074. doi: 10.1016/s0140-6736(81)91276-9. [DOI] [PubMed] [Google Scholar]
  34. Gracey M., Burke V., Anderson C. M. Assessment of medium-chain triglyceride feeding in infants with cystic fibrosis. Arch Dis Child. 1969 Jun;44(235):401–403. doi: 10.1136/adc.44.235.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Graham D. Y. Pancreatic enzyme replacement: the effect of antacids or cimetidine. Dig Dis Sci. 1982 Jun;27(6):485–490. doi: 10.1007/BF01296725. [DOI] [PubMed] [Google Scholar]
  36. HARRIS R., NORMAN A. P., PAYNE W. W. The effect of pancreatin therapy on fat absorption and nitrogen retention in children with fibrocystic disease of the pancreas. Arch Dis Child. 1955 Oct;30(153):424–427. doi: 10.1136/adc.30.153.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Hanly J. G., McKenna M. J., Quigley C., Freaney R., Muldowney F. P., FitzGerald M. X. Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med. 1985 Jul;56(219):377–385. [PubMed] [Google Scholar]
  38. Harries J. T., Muller D. P., McCollum J. P., Lipson A., Roma E., Norman A. P. Intestinal bile salts in cystic fibrosis: studies in the patient and experimental animal. Arch Dis Child. 1979 Jan;54(1):19–24. doi: 10.1136/adc.54.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hubbard V. S., Mangrum P. J. Energy intake and nutrition counseling in cystic fibrosis. J Am Diet Assoc. 1982 Feb;80(2):127–131. [PubMed] [Google Scholar]
  40. Imrie J. R., Fagan D. G., Sturgess J. M. Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am J Pathol. 1979 Jun;95(3):697–708. [PMC free article] [PubMed] [Google Scholar]
  41. Jones B. J., Brown B. E., Loran J. S., Edgerton D., Kennedy J. F., Stead J. A., Silk D. B. Glucose absorption from starch hydrolysates in the human jejunum. Gut. 1983 Dec;24(12):1152–1160. doi: 10.1136/gut.24.12.1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kelleher J., Goode H. F., Field H. P., Walker B. E., Miller M. G., Littlewood J. M. Essential element nutritional status in cystic fibrosis. Hum Nutr Appl Nutr. 1986 Apr;40(2):79–84. [PubMed] [Google Scholar]
  43. Kelleher J. Laboratory measurement of nutrition in cystic fibrosis. J R Soc Med. 1987;80 (Suppl 15):25–29. [PMC free article] [PubMed] [Google Scholar]
  44. King A., Mueller R. F., Heeley A. F., Robertson N. R. Diagnosis of cystic fibrosis in premature infants. Pediatr Res. 1986 Jun;20(6):536–541. doi: 10.1203/00006450-198606000-00011. [DOI] [PubMed] [Google Scholar]
  45. Kraemer R., Rüdeberg A., Hadorn B., Rossi E. Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand. 1978 Jan;67(1):33–37. doi: 10.1111/j.1651-2227.1978.tb16273.x. [DOI] [PubMed] [Google Scholar]
  46. Kuo P. T., Huang N. N. The effect of medium chain triglyceride upon fat absorption and plasma lipid and depot fat of children with cystic fibrosis of the pancreas. J Clin Invest. 1965 Nov;44(11):1924–1933. doi: 10.1172/JCI105298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Laughlin J. J., Brady M. S., Eigen H. Changing feeding trends as a cause of electrolyte depletion in infants with cystic fibrosis. Pediatrics. 1981 Aug;68(2):203–207. [PubMed] [Google Scholar]
  48. Levy L. D., Durie P. R., Pencharz P. B., Corey M. L. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr. 1985 Aug;107(2):225–230. doi: 10.1016/s0022-3476(85)80130-x. [DOI] [PubMed] [Google Scholar]
  49. Lloyd-Still J. D., Simon S. H., Wessel H. U., Gibson L. E. Negative effects of oral fatty acid supplementation on sweat chloride in cystic fibrosis. Pediatrics. 1979 Jul;64(1):50–52. [PubMed] [Google Scholar]
  50. Mitchell-Heggs P., Mearns M., Batten J. C. Cystic fibrosis in adolescents and adults. Q J Med. 1976 Jul;45(179):479–504. [PubMed] [Google Scholar]
  51. Morin C. L., Roy C. C., Lasalle R., Bonin A. Small bowel mucosal dysfunction in patients with cystic fibrosis. J Pediatr. 1976 Feb;88(2):213–216. doi: 10.1016/s0022-3476(76)80984-5. [DOI] [PubMed] [Google Scholar]
  52. Niessen K. H., Wolf A. Studies on the cause of hyperuricosuria in cystic fibrosis patients. J Pediatr Gastroenterol Nutr. 1982;1(3):349–354. doi: 10.1097/00005176-198201030-00012. [DOI] [PubMed] [Google Scholar]
  53. Oppenheimer E. H., Esterly J. R. Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases. Perspect Pediatr Pathol. 1975;2:241–278. [PubMed] [Google Scholar]
  54. Parsons H. G., Beaudry P., Dumas A., Pencharz P. B. Energy needs and growth in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1983;2(1):44–49. doi: 10.1097/00005176-198302010-00005. [DOI] [PubMed] [Google Scholar]
  55. Penny D. J., Ingall C. B., Boulton P., Walker-Smith J. A., Basheer S. M. Intestinal malabsorption in cystic fibrosis. Arch Dis Child. 1986 Nov;61(11):1127–1128. doi: 10.1136/adc.61.11.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Raziuddin K., Kim M. H., Yao A. C. Peripheral circulatory response to feeding in newborn low-birth-weight infants. J Pediatr Gastroenterol Nutr. 1984;3(1):89–94. doi: 10.1097/00005176-198401000-00019. [DOI] [PubMed] [Google Scholar]
  57. Regan P. T., Malagelada J. R., DiMagno E. P., Glanzman S. L., Go V. L. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med. 1977 Oct 20;297(16):854–858. doi: 10.1056/NEJM197710202971603. [DOI] [PubMed] [Google Scholar]
  58. Roy C. C., Delage G., Fontaine A., Robitaille L., Chartrand L., Weber A., Morin C. L. The fecal microflora and bile acids in children with cystic fibrosis. Am J Clin Nutr. 1979 Dec;32(12):2404–2409. doi: 10.1093/ajcn/32.12.2404. [DOI] [PubMed] [Google Scholar]
  59. SHWACHMAN H., KULCZYCKI L. L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958 Jul;96(1):6–15. doi: 10.1001/archpedi.1958.02060060008002. [DOI] [PubMed] [Google Scholar]
  60. Shepherd R., Cooksley W. G., Cooke W. D. Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis. J Pediatr. 1980 Sep;97(3):351–357. doi: 10.1016/s0022-3476(80)80180-6. [DOI] [PubMed] [Google Scholar]
  61. Shmerling D. H., Forrer J. C., Prader A. Fecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion. Pediatrics. 1970 Nov;46(5):690–695. [PubMed] [Google Scholar]
  62. Silk D. B., Fairclough P. D., Clark M. L., Hegarty J. E., Marrs T. C., Addison J. M., Burston D., Clegg K. M., Matthews D. M. Use of a peptide rather than free amino acid nitrogen source in chemically defined "elemental" diets. JPEN J Parenter Enteral Nutr. 1980 Nov-Dec;4(6):548–553. doi: 10.1177/0148607180004006548. [DOI] [PubMed] [Google Scholar]
  63. Silk D. B. Peptide transport. Clin Sci (Lond) 1981 Jun;60(6):607–615. doi: 10.1042/cs0600607. [DOI] [PubMed] [Google Scholar]
  64. Smalley C. A., Brown G. A., Parkes M. E., Tease H., Brookes V., Anderson C. M. Reduction of bile acid loss in cystic fibrosis by dietary means. Arch Dis Child. 1978 Jun;53(6):477–482. doi: 10.1136/adc.53.6.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Soutter V. L., Kristidis P., Gruca M. A., Gaskin K. J. Chronic undernutrition/growth retardation in cystic fibrosis. Clin Gastroenterol. 1986 Jan;15(1):137–155. [PubMed] [Google Scholar]
  66. Tanner M. S. Current clinical management of hepatic problems in cystic fibrosis. J R Soc Med. 1986;79 (Suppl 12):38–43. [PMC free article] [PubMed] [Google Scholar]
  67. Topouzian N., Joseph B. J., Bezkorovainy A. Effect of various metals and calcium metabolism inhibitors on the growth of Bifidobacterium bifidum var. pennsylvanicus. J Pediatr Gastroenterol Nutr. 1984;3(1):137–142. doi: 10.1097/00005176-198401000-00026. [DOI] [PubMed] [Google Scholar]
  68. Watkins J. B., Tercyak A. M., Szczepanik P., Klein P. D. Bile salt kinetics in cystic fibrosis: influence of pancreatic enzyme replacement. Gastroenterology. 1977 Nov;73(5):1023–1028. [PubMed] [Google Scholar]
  69. Weber A. M., Roy C. C., Morin C. L., Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med. 1973 Nov 8;289(19):1001–1005. doi: 10.1056/NEJM197311082891903. [DOI] [PubMed] [Google Scholar]
  70. Wilson-Sharp R. C., Irving H. C., Brown R. C., Chalmers D. M., Littlewood J. M. Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis. Arch Dis Child. 1984 Oct;59(10):923–926. doi: 10.1136/adc.59.10.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Wong L. T., Turtle S., Davidson A. G. Secretin pancreozymin stimulation test and confirmation of the diagnosis of cystic fibrosis. Gut. 1982 Sep;23(9):744–750. doi: 10.1136/gut.23.9.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Woods D. E., Straus D. C., Johanson W. G., Jr, Bass J. A. Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest. 1981 Dec;68(6):1435–1440. doi: 10.1172/JCI110395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Yassa J. G., Prosser R., Dodge J. A. Effects of an artificial diet on growth of patients with cystic fibrosis. Arch Dis Child. 1978 Oct;53(10):777–783. doi: 10.1136/adc.53.10.777. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES